Kohta Miyawaki

7PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Oct 08, 2025
Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipient.

Kohta Miyawaki, Hidetaka Nakagaki, Yasuo Mori

|Mar 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.

Michitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige

|Mar 17, 2023
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.

Kana Miyazaki, Rika Sakai, Noriko Iwaki

|Feb 22, 2023
Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus.

Sho Fujimoto, Yojiro Arinobu, Kohta Miyawaki

|Aug 31, 2022
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function.

Yoshikane Kikushige, Toshihiro Miyamoto, Yu Kochi

Pageof 2

Frequent Collaborators

2 joint publications

Takeshi Sugio

2 joint publications

Koji Kato

2 joint publications

Ritsuro Suzuki

2 joint publications

Koji Izutsu